Is Gammagard the One the Alzheimer's Community Has Been Waiting For?

This is the first study to report long term stabilization of Alzheimer's symptoms over a period of 36 months .

Alzheimer's Reading Room

We now have the first study in almost a decade that is reporting long term stabilization of Alzheimer's disease symptoms in patients.

Eleven patients who were treated over a 36 month period with IVIG/Gammagard had favorable outcomes in terms of their thinking abilities, behavior and daily function.

To be clear, the already existing symptoms of the Alzheimer's patients being studied did not improve; however, patients did not show any further decline on measures of cognition, memory, daily functioning or mood over the three years.

Continued on the Next Page